EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
EORTC SPRINT clinical cancer study receives support from Rising [...]
EORTC SPRINT clinical cancer study receives support from Rising [...]
Pink October at EORTC: Over 60 years of impactful [...]
TOPGEAR trial-results show no significant benefit of chemoradiotherapy before [...]
EORTC at ESMO 2024 [...]
OUR 2023 ANNUAL REPORT IS OUT! [...]